All Viruses articles – Page 8
-
News‘FluWarning’ system raises early alerts for virus spillovers
How can we monitor the cross-species transmission of avian flu? The answer is FluWarning, a digital system that reports abnormal changes in flu viruses. It analyses their genetic code, looking for subtle but significant changes that could indicate cross-species transmission.
-
NewsNew vaccine against a deadly virus acts fast and protects for over a year
A research team has developed a vaccine made from a non-infectious version of the Crimean-Congo hemorrhagic fever virus that protects quickly and provides long-lasting immunity.
-
NewsNew flu strain underscores urgent need for vigilance, vaccination, and investment in virus science
Virologists have issued a statement on the emergence of a new influenza A (H3N2) variant known as H3N2 subclade K that is spreading rapidly and may contribute to a more intense flu season worldwide. Public health agencies have reported sharp week-over-week increases in cases driven by this subclade.
-
NewsScientists uncover how COVID-19 variants outsmart the immune system
Researchers have created the most comprehensive map to date showing how antibodies attach to the SARS-CoV-2 virus, which causes COVID-19, and how viral mutations weaken that attachment.
-
NewsTeam discovers cyanobacteria activate different genes by day and by night
By analyzing gene expression in the cyanobacterium Nostoc punctiforme, scientists discovered that during daylight, the cells focus on metabolism. But under cover of darkness, they turn to the control of genome repair and activate various genetic elements.
-
NewsGlobal Virus Network awards pandemic preparedness grants to advance global surveillance and early detection of viral threats
The Global Virus Network (GVN) is awarding pandemic preparedness research grants, totaling $160,000, to scientists across four continents, supporting innovative, investigator-led projects designed to enhance viral surveillance, early detection, and scientific preparedness.
-
NewsNew research confirms HPV vaccination prevents cervical cancer
Two new Cochrane reviews show strong and consistent evidence that HPV vaccines are effective in preventing cervical cancer and pre-cancerous changes, especially when given to young people before they are exposed to the virus.
-
NewsRebalancing lung repair with immune damage is key to surviving severe influenza
Recovery from deadly influenza infection may hinge on helping the lungs heal in addition to stopping the virus, according to a new study in mice, which shows that pairing modest antiviral therapies with immune modulation can restore damaged tissues and lung function, even after severe infection has taken hold.
-
NewsScripps Research scientists receive $1.1 million to advance AI modeling for HIV vaccine development
Scripps Research scientists will purchase high-performance computing equipment to accelerate the identification of more effective HIV vaccine candidates through enhanced computational infrastructure, reduced data-processing bottlenecks, and state-of-the-art artificial intelligence (AI) technology.
-
NewsResearchers expand virus-based treatment options for antibiotic-resistant infections
Phages are extremely specific about which strains of a bacterial species they will attack. This has limited their effectiveness against the most antibiotic-resistant strains. To overcome this problem, the research team “trained” the phages by allowing them to evolve together with the bacteria in a controlled laboratory setting for 30 days.
-
NewsHepatitis E virus from rats can also infect humans in individual cases – a new zoonotic pathogen?
It has only been known for a few years that humans can also be infected with a variant of the hepatitis E virus that is usually prevalent in rats. Following reports of individual cases, mainly from Hong Kong and Spain, the first infection with ratHEV has now also been described in a patient from Germany.
-
NewsPig disease vaccine effectiveness linked to T cell response
A new study shows that the effectiveness of current vaccines against porcine reproductive and respiratory syndrome virus (PRRSV) is due to the response of T cells against the disease, rather than the production of antibodies. The work is an important step in identifying specific targets for vaccines on a rapidly mutating virus.
-
NewsAMI warns that the threat of antimicrobial resistance in viruses and other pathogens cannot be underestimated
Applied Microbiology International (AMI) has urged global policymakers to strengthen the revised Global Action Plan on Antimicrobial Resistance (GAP-AMR), calling for a more inclusive, clear and equitable approach to tackling one of the world’s most urgent health challenges.
-
NewsStudy in Europe: monoclonal antibodies effectively prevent respiratory syncytial virus in infants
Data from Belgium, Portugal and Spain show that immunisation of children after birth reduced the risk of hospitalization due to RSV infection by almost 80%.
-
NewsWild birds are driving the current U.S. bird flu outbreak
Researchers traced the introduction and spread of highly pathogenic H5N1 viruses during the first 18 months in North America using genomic sequencing and migratory flyway analysis, discovering that the viruses were spread primarily by wild migrating birds.
-
NewsWomen are three times more likely than men to get severe long COVID: Here’s why
Researchers have identified a distinct immune signature in female long Covid patients versus male patients. They found evidence of ’gut leakiness’ in the women patients, including elevated blood levels of intestinal fatty acid binding protein, lipopolysaccharide, and the soluble protein CD14 — all signs of gut inflammation that can then trigger further systemic inflammation.
-
NewsProtecting infants against respiratory syncytial virus this winter — ECDC issues advice
ECDC has issued rapid scientific advice for policymakers and public health authorities on ways to mitigate the impact of RSV disease among infants through immunisation and to support intensified efforts to protect them from RSV across Europe.
-
NewsExperts urge continued hepatitis B vaccine birth doses for newborns
In a new commentary, leading experts urge that all newborns in the United States continue to receive the first dose of hepatitis B vaccine within 24 hours of birth. Hepatitis B vaccines are safe and effective with over one billion doses administered worldwide.
-
NewsKorea University College of Medicine’s Vaccine Innovation Center selected as lead institution for 2025 Korea-ARPA-H Health Security Project
The Vaccine Innovation Center at Korea University College of Medicine has been selected as the lead institution for a health security research initiative under the Ministry of Health and Welfare’s “2025 Korea-ARPA-H Project.”
-
NewsAvian flu halves South Georgia’s breeding elephant seal population
South Georgia’s breeding population of female southern elephant seals (Mirounga leonina) may have been halved by highly pathogenic avian influenza virus (HPAIV), finds new research. These losses may threaten the security of the island’s breeding population.